SML1530

SB-334867

≥98% (HPLC)

• Sinónimos: N-(2-Methyl-6-benzoxazolyl)-N′-1,5-naphthyridin-4-yl-urea, SB-334867, SB-334867A, SB334867
• Fórmula empírica (notación de Hill): C₁₇H₁₃N₅O₂
• Número CAS: 792173-99-0
• Peso molecular: 319.32
• NACRES: NA.77
• PubChem Substance ID: 329825947
• UNSPSC Code: 51111800
• MDL number: MFCD06411602
• Assay: ≥98% (HPLC)
• Form: powder
• Storage condition: desiccated

Propiedades

• Quality Segment: 100
• assay: ≥98% (HPLC)
• form: powder
• storage condition: desiccated
• color: white to beige
• solubility: DMSO: 5 mg/mL, clear (warmed)
• storage temp.: room temp
• SMILES string: O=C(NC1=CC=C(N=C(C)O2)C2=C1)NC3=CC=NC4=C3N=CC=C4
• InChI: 1S/C17H13N5O2/c1-10-20-12-5-4-11(9-15(12)24-10)21-17(23)22-14-6-8-18-13-3-2-7-19-16(13)14/h2-9H,1H3,(H2,18,21,22,23)
• InChI key: AKMNUCBQGHFICM-UHFFFAOYSA-N

Descripción

Biochem/physiol Actions

SB-334867 is a non-peptide selective antagonist of the orexin OX1 receptor.

SB-334867 is a non-peptide selective antagonist of the orexin OX1 receptor. SB-334867 blocks orexin-A induced calcium response with a pKb of 7.23. SB-334867 blocks increases in heart rate and body temperature induced by administratin of methamphetamine, and can inhibit the development of tolerance to the analgesic properties of morphine in rodent models. SB-334867 also shows anxiolytic and sedative effects.

Lateral hypothalamic orexin neuron activation leads to the development of morphine conditioned place preference, which is preferably blocked by SB-334867.

Información de seguridad

• Pictogramas: GHS07
• Palabra de advertencia: Warning
• Códigos de peligro: H315
• Indicaciones de precaución: P264 - P280 - P302 + P352 - P332 + P313 - P362 + P364
• Hazard Classifications: Skin Irrit. 2
• Clase de almacenamiento: 11 - Combustible Solids
• WGK: WGK 3
• Punto de inflamación (°F): Not applicable
• Punto de inflamación (°C): Not applicable